Wednesday, 6 December 2017

NEURALSTEM PRESENTS POSITIVE UPDATED DATA FROM PHASE 2 STUDY OF NSI-189 IN MAJOR DEPRESSIVE DISORDER AT THE 56TH AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY (ACNP) ANNUAL MEETING

NEURALSTEM PRESENTS POSITIVE UPDATED DATA FROM PHASE 2 STUDY OF NSI-189 IN MAJOR DEPRESSIVE DISORDER AT THE 56TH AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY (ACNP) ANNUAL MEETING

No comments:

Post a Comment